BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//GrantMe Tennessee//grantme.click//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:GrantMe: Black
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:2b7d455f-87e2-4efa-9e0a-2f85bd07a087-close@grantme.click
DTSTAMP:20261008T014056Z
DTSTART;VALUE=DATE:20261009
DTEND;VALUE=DATE:20261010
SUMMARY:Deadline: Research and Education Program for Historically Black Col
 leges and Universities (HBCU) and Tribal Colleges and Universities (TCU) E
 quipment/Instrumentation
URL:https://grantme.click/grants/2b7d455f-87e2-4efa-9e0a-2f85bd07a087
DESCRIPTION:Confirm the deadline and time zone on the funder's official pag
 e.
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:a6f11a50-4beb-4892-b25f-9f3d83fc572f-close@grantme.click
DTSTAMP:20261008T014056Z
DTSTART;VALUE=DATE:20261014
DTEND;VALUE=DATE:20261015
SUMMARY:Deadline: Revision Applications for Validation of Biomarker Assays 
 Developed Through NIH-Supported Research Grants (R01 Clinical Trial Not Al
 lowed)
URL:https://grantme.click/grants/a6f11a50-4beb-4892-b25f-9f3d83fc572f
DESCRIPTION:Confirm the deadline and time zone on the funder's official pag
 e.
TRANSP:TRANSPARENT
BEGIN:VALARM
ACTION:DISPLAY
TRIGGER:-P7D
DESCRIPTION:7 days left: Deadline: Revision Applications for Validation of 
 Biomarker Assays Developed Through NIH-Supported Research Grants (R01 Clin
 ical Trial Not Allowed)
END:VALARM
END:VEVENT
BEGIN:VEVENT
UID:44af54ae-5861-4cfe-8195-1b66e466fd8f-close@grantme.click
DTSTAMP:20261008T014056Z
DTSTART;VALUE=DATE:20261014
DTEND;VALUE=DATE:20261015
SUMMARY:Deadline: Assay Validation of High Quality Markers for Clinical Stu
 dies in Cancer (UH2/UH3 Clinical Trial Not Allowed)
URL:https://grantme.click/grants/44af54ae-5861-4cfe-8195-1b66e466fd8f
DESCRIPTION:Confirm the deadline and time zone on the funder's official pag
 e.
TRANSP:TRANSPARENT
BEGIN:VALARM
ACTION:DISPLAY
TRIGGER:-P7D
DESCRIPTION:7 days left: Deadline: Assay Validation of High Quality Markers
  for Clinical Studies in Cancer (UH2/UH3 Clinical Trial Not Allowed)
END:VALARM
END:VEVENT
BEGIN:VEVENT
UID:77f82926-a28f-4c25-9439-aec7d61df781-close@grantme.click
DTSTAMP:20261008T014056Z
DTSTART;VALUE=DATE:20261014
DTEND;VALUE=DATE:20261015
SUMMARY:Deadline: NCI Pathway to Independence Award for Early-Stage Postdoc
 toral Researchers (K99/R00 - Independent Clinical Trial Required)
URL:https://grantme.click/grants/77f82926-a28f-4c25-9439-aec7d61df781
DESCRIPTION:Confirm the deadline and time zone on the funder's official pag
 e.
TRANSP:TRANSPARENT
BEGIN:VALARM
ACTION:DISPLAY
TRIGGER:-P7D
DESCRIPTION:7 days left: Deadline: NCI Pathway to Independence Award for Ea
 rly-Stage Postdoctoral Researchers (K99/R00 - Independent Clinical Trial R
 equired)
END:VALARM
END:VEVENT
BEGIN:VEVENT
UID:8a904792-96dd-46d5-b0dd-ae13e0520f95-close@grantme.click
DTSTAMP:20261008T014056Z
DTSTART;VALUE=DATE:20261014
DTEND;VALUE=DATE:20261015
SUMMARY:Deadline: NCI Pathway to Independence Award for Early-Stage Postdoc
 toral Researchers (K99/R00 - Independent Clinical Trial Not Allowed)
URL:https://grantme.click/grants/8a904792-96dd-46d5-b0dd-ae13e0520f95
DESCRIPTION:Confirm the deadline and time zone on the funder's official pag
 e.
TRANSP:TRANSPARENT
BEGIN:VALARM
ACTION:DISPLAY
TRIGGER:-P7D
DESCRIPTION:7 days left: Deadline: NCI Pathway to Independence Award for Ea
 rly-Stage Postdoctoral Researchers (K99/R00 - Independent Clinical Trial N
 ot Allowed)
END:VALARM
END:VEVENT
BEGIN:VEVENT
UID:327952bc-486e-468c-b4ab-ef2cf6f6c81a-close@grantme.click
DTSTAMP:20261008T014056Z
DTSTART;VALUE=DATE:20261014
DTEND;VALUE=DATE:20261015
SUMMARY:Deadline: Assay Validation of High Quality Markers for Clinical Stu
 dies in Cancer (UH3 Clinical Trials Not Allowed)
URL:https://grantme.click/grants/327952bc-486e-468c-b4ab-ef2cf6f6c81a
DESCRIPTION:Confirm the deadline and time zone on the funder's official pag
 e.
TRANSP:TRANSPARENT
BEGIN:VALARM
ACTION:DISPLAY
TRIGGER:-P7D
DESCRIPTION:7 days left: Deadline: Assay Validation of High Quality Markers
  for Clinical Studies in Cancer (UH3 Clinical Trials Not Allowed)
END:VALARM
END:VEVENT
END:VCALENDAR
